These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2423714)

  • 41. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):36-9. PubMed ID: 166960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation.
    Harvey JA; Zobitz MM; Pak CY
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1223-5. PubMed ID: 4055988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine.
    Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL
    J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concentrated urine and diluted urine: the effects of citrate and magnesium on the crystallization of calcium oxalate induced in vitro by an oxalate load.
    Guerra A; Meschi T; Allegri F; Prati B; Nouvenne A; Fiaccadori E; Borghi L
    Urol Res; 2006 Dec; 34(6):359-64. PubMed ID: 16953377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pyrophosphate does not influence calcium oxalate or calcium phosphate crystal formation in concentrated whole human urine.
    Hallson PC; Rose GA; Sulaiman S
    Urol Res; 1983; 11(4):151-4. PubMed ID: 6316611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of weddellite formation: chondroitin sulfates and citrate determine weddellite formation in vitro.
    Kim KM
    Scanning Microsc; 1996; 10(2):445-55; discussion 455-7. PubMed ID: 9813623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experiences with the measurement of inhibitory activity of urine and crystallisation inhibitors by different techniques.
    Baumann JM; Wacker M
    Urol Res; 1979 Sep; 7(3):183-8. PubMed ID: 228455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surface interaction between glycosaminoglycans and calcium oxalate.
    Angell AH; Resnick MI
    J Urol; 1989 May; 141(5):1255-8. PubMed ID: 2709520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitors of oxalocalcic lithiasis: effects of their interactions on calcium oxalate crystallization.
    Muñoz JA; López-Mesas M; Valiente M
    Urology; 2012 Nov; 80(5):1163.e13-8. PubMed ID: 22748613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of stone-forming risk by measuring crystal formation in whole urine with gel model.
    Roehrborn CG; Schneider HJ; Rugendorff EW
    Urology; 1986 Jun; 27(6):531-6. PubMed ID: 3716052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cooperative effects of Na
    Shanthil M; Sandeep K; Sajith PK
    Phys Chem Chem Phys; 2020 Feb; 22(8):4788-4792. PubMed ID: 32068201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aspects on estimation of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Int; 1991; 47(4):255-9. PubMed ID: 1781112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Artificial simulation of renal stone formation. Influence of some urinary components.
    Grases F; Costa-Bauzá A; March JG; Söhnel O
    Nephron; 1993; 65(1):77-81. PubMed ID: 8413796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.